▶ 調査レポート

世界の副腎皮質刺激ホルモン受容体市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Adrenocorticotropic Hormone Receptor Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の副腎皮質刺激ホルモン受容体市場 2021:企業別、地域別、種類・用途別 / Global Adrenocorticotropic Hormone Receptor Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A14906資料のイメージです。• レポートコード:GIR-107A14906
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、81ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、副腎皮質刺激ホルモン受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。副腎皮質刺激ホルモン受容体の種類別市場規模(AQB-565、BIM-23B065、コルチコトロピン、その他)、用途別市場規模(ホルモン障害、筋骨格系障害、クッシング病、先端巨大症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・副腎皮質刺激ホルモン受容体の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Alder Biopharmaceuticals Inc.、Ipsen S.A.、Mallinckrodt Plc、Pfizer Inc.、Retrophin Inc.、XOMA Corporation
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:AQB-565、BIM-23B065、コルチコトロピン、その他
・用途別分析2016年-2026年:ホルモン障害、筋骨格系障害、クッシング病、先端巨大症、その他
・副腎皮質刺激ホルモン受容体の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・副腎皮質刺激ホルモン受容体のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・副腎皮質刺激ホルモン受容体のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・副腎皮質刺激ホルモン受容体の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・副腎皮質刺激ホルモン受容体の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Adrenocorticotropic Hormone Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Adrenocorticotropic Hormone Receptor size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Adrenocorticotropic Hormone Receptor market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Adrenocorticotropic Hormone Receptor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
AQB-565
BIM-23B065
Corticotropin
Others

Market segment by Application, can be divided into
Hormonal Disorder
Musculoskeletal Disorder
Cushing Disease
Acromegaly
Others

Market segment by players, this report covers
Alder Biopharmaceuticals Inc.
Ipsen S.A.
Mallinckrodt Plc
Pfizer Inc.
Retrophin Inc.
XOMA Corporation

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Adrenocorticotropic Hormone Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Adrenocorticotropic Hormone Receptor, with revenue, gross margin and global market share of Adrenocorticotropic Hormone Receptor from 2019 to 2021.
Chapter 3, the Adrenocorticotropic Hormone Receptor competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Adrenocorticotropic Hormone Receptor market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Adrenocorticotropic Hormone Receptor research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Adrenocorticotropic Hormone Receptor
1.2 Classification of Adrenocorticotropic Hormone Receptor by Type
1.2.1 Overview: Global Adrenocorticotropic Hormone Receptor Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Type in 2020
1.2.3 AQB-565
1.2.4 BIM-23B065
1.2.5 Corticotropin
1.2.6 Others
1.3 Global Adrenocorticotropic Hormone Receptor Market by Application
1.3.1 Overview: Global Adrenocorticotropic Hormone Receptor Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hormonal Disorder
1.3.3 Musculoskeletal Disorder
1.3.4 Cushing Disease
1.3.5 Acromegaly
1.3.6 Others
1.4 Global Adrenocorticotropic Hormone Receptor Market Size & Forecast
1.5 Global Adrenocorticotropic Hormone Receptor Market Size and Forecast by Region
1.5.1 Global Adrenocorticotropic Hormone Receptor Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Adrenocorticotropic Hormone Receptor Market Size by Region, (2016-2021)
1.5.3 North America Adrenocorticotropic Hormone Receptor Market Size and Prospect (2016-2026)
1.5.4 Europe Adrenocorticotropic Hormone Receptor Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Adrenocorticotropic Hormone Receptor Market Size and Prospect (2016-2026)
1.5.6 South America Adrenocorticotropic Hormone Receptor Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Adrenocorticotropic Hormone Receptor Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adrenocorticotropic Hormone Receptor Market Drivers
1.6.2 Adrenocorticotropic Hormone Receptor Market Restraints
1.6.3 Adrenocorticotropic Hormone Receptor Trends Analysis
2 Company Profiles
2.1 Alder Biopharmaceuticals Inc.
2.1.1 Alder Biopharmaceuticals Inc. Details
2.1.2 Alder Biopharmaceuticals Inc. Major Business
2.1.3 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Product and Solutions
2.1.4 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Alder Biopharmaceuticals Inc. Recent Developments and Future Plans
2.2 Ipsen S.A.
2.2.1 Ipsen S.A. Details
2.2.2 Ipsen S.A. Major Business
2.2.3 Ipsen S.A. Adrenocorticotropic Hormone Receptor Product and Solutions
2.2.4 Ipsen S.A. Adrenocorticotropic Hormone Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Ipsen S.A. Recent Developments and Future Plans
2.3 Mallinckrodt Plc
2.3.1 Mallinckrodt Plc Details
2.3.2 Mallinckrodt Plc Major Business
2.3.3 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Product and Solutions
2.3.4 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Mallinckrodt Plc Recent Developments and Future Plans
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Adrenocorticotropic Hormone Receptor Product and Solutions
2.4.4 Pfizer Inc. Adrenocorticotropic Hormone Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Inc. Recent Developments and Future Plans
2.5 Retrophin Inc.
2.5.1 Retrophin Inc. Details
2.5.2 Retrophin Inc. Major Business
2.5.3 Retrophin Inc. Adrenocorticotropic Hormone Receptor Product and Solutions
2.5.4 Retrophin Inc. Adrenocorticotropic Hormone Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Retrophin Inc. Recent Developments and Future Plans
2.6 XOMA Corporation
2.6.1 XOMA Corporation Details
2.6.2 XOMA Corporation Major Business
2.6.3 XOMA Corporation Adrenocorticotropic Hormone Receptor Product and Solutions
2.6.4 XOMA Corporation Adrenocorticotropic Hormone Receptor Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 XOMA Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Adrenocorticotropic Hormone Receptor Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Adrenocorticotropic Hormone Receptor Players Market Share
3.2.2 Top 10 Adrenocorticotropic Hormone Receptor Players Market Share
3.2.3 Market Competition Trend
3.3 Adrenocorticotropic Hormone Receptor Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Adrenocorticotropic Hormone Receptor Revenue and Market Share by Type (2016-2021)
4.2 Global Adrenocorticotropic Hormone Receptor Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Application (2016-2021)
5.2 Adrenocorticotropic Hormone Receptor Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2026)
6.2 North America Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2026)
6.3 North America Adrenocorticotropic Hormone Receptor Market Size by Country
6.3.1 North America Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2026)
6.3.2 United States Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
6.3.3 Canada Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
6.3.4 Mexico Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2026)
7.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2026)
7.3 Europe Adrenocorticotropic Hormone Receptor Market Size by Country
7.3.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2026)
7.3.2 Germany Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
7.3.3 France Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
7.3.5 Russia Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
7.3.6 Italy Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2026)
8.2 Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2026)
8.3 Asia-Pacific Adrenocorticotropic Hormone Receptor Market Size by Region
8.3.1 Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Region (2016-2026)
8.3.2 China Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
8.3.3 Japan Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
8.3.4 South Korea Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
8.3.5 India Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
8.3.7 Australia Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2026)
9.2 South America Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2026)
9.3 South America Adrenocorticotropic Hormone Receptor Market Size by Country
9.3.1 South America Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2026)
9.3.2 Brazil Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
9.3.3 Argentina Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2026)
10.2 Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2026)
10.3 Middle East & Africa Adrenocorticotropic Hormone Receptor Market Size by Country
10.3.1 Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2026)
10.3.2 Turkey Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
10.3.4 UAE Adrenocorticotropic Hormone Receptor Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Adrenocorticotropic Hormone Receptor Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Adrenocorticotropic Hormone Receptor Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Adrenocorticotropic Hormone Receptor Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Adrenocorticotropic Hormone Receptor Revenue (USD Million) by Region (2016-2021)
Table 5. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Region (2021-2026)
Table 6. Alder Biopharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Alder Biopharmaceuticals Inc. Major Business
Table 8. Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Product and Solutions
Table 9. Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Ipsen S.A. Corporate Information, Head Office, and Major Competitors
Table 11. Ipsen S.A. Major Business
Table 12. Ipsen S.A. Adrenocorticotropic Hormone Receptor Product and Solutions
Table 13. Ipsen S.A. Adrenocorticotropic Hormone Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Mallinckrodt Plc Corporate Information, Head Office, and Major Competitors
Table 15. Mallinckrodt Plc Major Business
Table 16. Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Product and Solutions
Table 17. Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Inc. Major Business
Table 20. Pfizer Inc. Adrenocorticotropic Hormone Receptor Product and Solutions
Table 21. Pfizer Inc. Adrenocorticotropic Hormone Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Retrophin Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Retrophin Inc. Major Business
Table 24. Retrophin Inc. Adrenocorticotropic Hormone Receptor Product and Solutions
Table 25. Retrophin Inc. Adrenocorticotropic Hormone Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. XOMA Corporation Corporate Information, Head Office, and Major Competitors
Table 27. XOMA Corporation Major Business
Table 28. XOMA Corporation Adrenocorticotropic Hormone Receptor Product and Solutions
Table 29. XOMA Corporation Adrenocorticotropic Hormone Receptor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Adrenocorticotropic Hormone Receptor Revenue (USD Million) by Players (2019-2021)
Table 31. Global Adrenocorticotropic Hormone Receptor Revenue Share by Players (2019-2021)
Table 32. Breakdown of Adrenocorticotropic Hormone Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Adrenocorticotropic Hormone Receptor Players Head Office, Products and Services Provided
Table 34. Adrenocorticotropic Hormone Receptor Mergers & Acquisitions in the Past Five Years
Table 35. Adrenocorticotropic Hormone Receptor New Entrants and Expansion Plans
Table 36. Global Adrenocorticotropic Hormone Receptor Revenue (USD Million) by Type (2016-2021)
Table 37. Global Adrenocorticotropic Hormone Receptor Revenue Share by Type (2016-2021)
Table 38. Global Adrenocorticotropic Hormone Receptor Revenue Forecast by Type (2021-2026)
Table 39. Global Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2021)
Table 40. Global Adrenocorticotropic Hormone Receptor Revenue Forecast by Application (2021-2026)
Table 41. North America Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Adrenocorticotropic Hormone Receptor Picture
Figure 2. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Type in 2020
Figure 3. AQB-565
Figure 4. BIM-23B065
Figure 5. Corticotropin
Figure 6. Others
Figure 7. Adrenocorticotropic Hormone Receptor Revenue Market Share by Application in 2020
Figure 8. Hormonal Disorder Picture
Figure 9. Musculoskeletal Disorder Picture
Figure 10. Cushing Disease Picture
Figure 11. Acromegaly Picture
Figure 12. Others Picture
Figure 13. Global Adrenocorticotropic Hormone Receptor Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Adrenocorticotropic Hormone Receptor Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Region (2016-2026)
Figure 16. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Region in 2020
Figure 17. North America Adrenocorticotropic Hormone Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Adrenocorticotropic Hormone Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Adrenocorticotropic Hormone Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Adrenocorticotropic Hormone Receptor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Adrenocorticotropic Hormone Receptor Market Drivers
Figure 23. Adrenocorticotropic Hormone Receptor Market Restraints
Figure 24. Adrenocorticotropic Hormone Receptor Market Trends
Figure 25. Alder Biopharmaceuticals Inc. Recent Developments and Future Plans
Figure 26. Ipsen S.A. Recent Developments and Future Plans
Figure 27. Mallinckrodt Plc Recent Developments and Future Plans
Figure 28. Pfizer Inc. Recent Developments and Future Plans
Figure 29. Retrophin Inc. Recent Developments and Future Plans
Figure 30. XOMA Corporation Recent Developments and Future Plans
Figure 31. Global Adrenocorticotropic Hormone Receptor Revenue Share by Players in 2020
Figure 32. Adrenocorticotropic Hormone Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Adrenocorticotropic Hormone Receptor Revenue Market Share in 2020
Figure 34. Global Top 10 Players Adrenocorticotropic Hormone Receptor Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Adrenocorticotropic Hormone Receptor Revenue Share by Type in 2020
Figure 37. Global Adrenocorticotropic Hormone Receptor Market Share Forecast by Type (2021-2026)
Figure 38. Global Adrenocorticotropic Hormone Receptor Revenue Share by Application in 2020
Figure 39. Global Adrenocorticotropic Hormone Receptor Market Share Forecast by Application (2021-2026)
Figure 40. North America Adrenocorticotropic Hormone Receptor Sales Market Share by Type (2016-2026)
Figure 41. North America Adrenocorticotropic Hormone Receptor Sales Market Share by Application (2016-2026)
Figure 42. North America Adrenocorticotropic Hormone Receptor Revenue Market Share by Country (2016-2026)
Figure 43. United States Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Adrenocorticotropic Hormone Receptor Sales Market Share by Type (2016-2026)
Figure 47. Europe Adrenocorticotropic Hormone Receptor Sales Market Share by Application (2016-2026)
Figure 48. Europe Adrenocorticotropic Hormone Receptor Revenue Market Share by Country (2016-2026)
Figure 49. Germany Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Adrenocorticotropic Hormone Receptor Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Adrenocorticotropic Hormone Receptor Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Adrenocorticotropic Hormone Receptor Revenue Market Share by Region (2016-2026)
Figure 57. China Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Adrenocorticotropic Hormone Receptor Sales Market Share by Type (2016-2026)
Figure 64. South America Adrenocorticotropic Hormone Receptor Sales Market Share by Application (2016-2026)
Figure 65. South America Adrenocorticotropic Hormone Receptor Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Adrenocorticotropic Hormone Receptor Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Adrenocorticotropic Hormone Receptor Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Adrenocorticotropic Hormone Receptor Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Adrenocorticotropic Hormone Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source